THE USE OF INTRAVENOUS IBUPROFEN IN POSTOPERATIVE PERIOD
BULLETIN OF SURGERY IN KAZAKHSTAN · 2022
DOI: 10.35805/bsk2022i055 ↗Kurz gefasst
Fachartikel in der Zeitschrift BULLETIN OF SURGERY IN KAZAKHSTAN, 2022. Verfasst von B. Shirtaev und 9 weiteren Autor:innen.
Abstract (Originalsprache)
The article reflects the role of non-steroidal anti-inflammatory drugs in postoperative period. The study was conducted on the data of 94 operations of children aged from 10 months to 15 years (mean age 4.4 years). All patients of our center with esophagocoloplasty in the postoperative period received the drug «Intrafen» in injectable form, intravenously. Name of manufacturer of drug: GEN ILAC VE SAGLIK URUNLERI SANAYI VE TICARET, A.S. (Turkey). The main active substance of this drug is Ibuprofen 400mg/4ml for intravenous injection. Patients were injected intravenous ibuprofen at therapeutically effective doses for a minimal period of time. After receiving positive reactions to the drug at the initial stage of treatment, the dose and frequency of taking the drug was adjusted individually for each patient.
Objective
This work is dedicated to evaluate the role of the intravenous Ibuprofen in the postoperative period in surgical practice. Material and methods. The study included 94 pediatric patients with esophagocoloplasty. Age of patients: from 10 months to 15 years (mean age 4.4 years), of which: 90 (96%) patients had post-burn stricture of the esophagus; 3 (3%) patients with esophageal atresia; 1 (1%) patient with a short esophagus. The number of female children - 51 (54.3%) patients, male - 43 (45.7%) patients.
Results
The total number of patients receiving intravenous Ibuprofen in the postoperative period was 94. The optimal dose showed a good therapeutic effect. At the optimal dosage of 20 mg/kg/day, two patients experienced intra-abdominal bleeding. Follow-up time: 2 weeks after esophagocoloplasty.
Conclusion
In patients with esophagocoloplasty, preventive intravenous administration of Ibuprofen showed a good therapeutic result. Patients noted a decrease in pain, which in turn led to a decrease in the need for emergency analgesia.
Zitieren
APA
Shirtaev, B., Yerimova, N., Sundetov, M., Khalykov, K., Kurbanov, D., Akhbetova, A., Akilbekov, S., Mukashev, S., Kanazov, A., & Bogdanova, D. (2022). THE USE OF INTRAVENOUS IBUPROFEN IN POSTOPERATIVE PERIOD. BULLETIN OF SURGERY IN KAZAKHSTAN. https://doi.org/10.35805/bsk2022i055
Vancouver
Shirtaev B, Yerimova N, Sundetov M, Khalykov K, Kurbanov D, Akhbetova A, et al. THE USE OF INTRAVENOUS IBUPROFEN IN POSTOPERATIVE PERIOD. BULLETIN OF SURGERY IN KAZAKHSTAN. 2022. doi:10.35805/bsk2022i055
BibTeX
@article{Shirtaev2022,
author = {Shirtaev, B. and Yerimova, N. and Sundetov, M. and Khalykov, K. and Kurbanov, D. and Akhbetova, A. and Akilbekov, S. and Mukashev, S. and Kanazov, A. and Bogdanova, D.},
title = {THE USE OF INTRAVENOUS IBUPROFEN IN POSTOPERATIVE PERIOD},
journal = {BULLETIN OF SURGERY IN KAZAKHSTAN},
year = {2022},
doi = {10.35805/bsk2022i055}
}
EUVIMED